1. Abe M, Takahashi M, Ono K, Tobe T, Inamoto T (1988) Japan gastric trials in intraoperative radiation therapy. IntJ RadiatOncol Biol Phys 15: 1431–1433
2. Adachi Y, Mimori K, Mori M, Maehara Y, Sugimachi K (1997) Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma. J Am Coll Surg 184: 240–244
3. Ajani JA, Van Cutsem E, Moiseyenko V et al. (2003) Docetaxel, cisplatin, 5-fluorouracil compare to cisplatin and 5-fluorouracil for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma: Interim results of a randomized phase III trial (V325). Proc Am Soc Clin Oncol 22: 249 (abstr 999).
4. Albert C (1995) Clinical aspects of gastric cancer. In: Rustgi AK (ed) Gastrointestinal cancer: biology, diagnosis, and therapy. Lippincott-Raven, Philadelphia, pp 197–216
5. Alexander HR, Grem JL, Hamilton JM et al. (1995) Thymidilate synthase protein expression: association with response to neoadjuvantchemotherapy and resection for locally advanced gastric and esophageal adenocarcinoma. Cancer J 1: 49–54